Real-time enrollment status for this mct8 deficiency clinical trial
Current Status
Completed
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT05579327 |
| Recruiting Status | Completed |
| Condition | MCT8 Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 16 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Rare Thyroid Therapeutics International AB |
| Last Updated on CT.gov | February 6, 2026 (3 weeks ago) |
As of March 2, 2026: Clinical trial NCT05579327 is currently completed participants. This clinical trial study for mct8 deficiency is not currently accepting new participants at 6 locations across the United States. The study is sponsored by Rare Thyroid Therapeutics International AB. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05579327 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05579327 was last updated 3 weeks ago (February 6, 2026). HelloStudys verifies this status automatically.